Homeopathic Treatment of Post-acute COVID-19 Syndrome
Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
To determine whether an individually prescribed homeopathic medicine has an effect greater
than a placebo and is a viable treatment option to improve fatigue and quality of life for
patients suffering from the symptoms of Post-acute COVID-19 Syndrome. The researchers hope to
achieve this goal by conducting a clinical trial that is scientifically rigorous and
clinically relevant. Expected results of this pilot study will be to obtain sufficient
experience and preliminary feasibility data to justify a larger clinical trial of this
hypothesis.